v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
REVENUES
OPERATING EXPENSES FROM CONTINUING OPERATIONS    
Compensation and related expenses 756,399 76,388
Professional fees 639,405 769,497
General and administrative 119,468 2,414,018
Research and development expenses 254,837 73,954
Total Operating Expenses 1,770,109 3,333,857
LOSS FROM CONTINUING OPERATIONS (1,770,109) (3,333,857)
OTHER INCOME (EXPENSE) FROM CONTINUING OPERATIONS    
Financing costs including interest (18,137) (37,629)
Other miscellaneous income
Gain on sale of equity method investment 100,000
Loss on debentures and accrued expenses converted to common stock (390,068)
Loss on conversion of bridge notes including accrued interest and debt forgiveness (744,505)
Total Other Expense, net (18,137) (1,072,202)
Loss from continuing operations before income taxes (1,788,246) (4,406,059)
INCOME TAXES
Loss from continuing operations (1,788,246) (4,406,059)
DISCONTINUED OPERATIONS:    
Income from discontinued operations before income taxes
INCOME TAXES
Income from discontinued operations
NET LOSS (1,788,246) (4,406,059)
PREFERRED STOCK    
Series A preferred stock contractual dividends (7,202) (7,899)
Series B preferred stock contractual dividends (37,206)
Deemed dividend on conversion of Series A preferred stock to shares of common stock (542,500)
Deemed dividend on warrant modification (41,225)
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS $ (1,873,879) $ (4,956,458)
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS: BASIC AND DILUTED:    
Loss per share $ (1.12) $ (8.76)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: 1,668,677 565,672